Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump.
Featured
Industry News NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Latest News
Industry News ARIXA PHARMACEUTICALS: Announces Publication of Seminal Paper Demonstrating First Oral Prodrug of Avibactam
Federal Issues
- U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States
- PHARMACEUTICAL CARE MANAGEMENT CARE ASSOCIATION: Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
- U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: HHS Secretary Azar Praises FDA Approval of First Non-Opioid Treatment for Opioid Withdrawal
Industry News
- THERAVANCE BIOPHARMA: Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals
- CVS PHARMACY: Completes Rollout of Time Delay Safes in All of Its Maryland Pharmacies
- UCF researchers awarded $400,000 grant to create new insulin delivery tube
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Applauds the Administration for Enacting Legislation to Ensure Patients Pay the Lowest Price for Prescription Drugs
Innovation
CERTARA: US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants
- AMGEN: Makes Repatha® (Evolocumab) Available In The US At A 60 Percent Reduced List Price
- UCF researchers awarded $400,000 grant to create new insulin delivery tube
- Study shows effects of body lotions on capillary blood glucose
- ACADEMY OF MANAGED CARE PHARMACY: AMCP Partnership Forum to Develop Consensus Roadmap for Managing Total Cost of Care by Integrating Medical and Pharmacy Data
Regulatory
.jpg){kind=tracking}
- U.S. FOOD AND DRUG ADMINISTRATION: FDA approves new drug to treat travelers’ diarrhea
- SANOFI: FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
- ACELRX PHARMACEUTICALS, INC.: Announces FDA approval of DSUVIA™
- PFIZER: U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC
Alerts Sign-up